Long Covid and ME/CFS: Research
The question
To ask the Secretary of State for Science, Innovation and Technology, what steps she is taking to support collaboration between Government-funded bodies and private-sector researchers following the identification on 4 December 2025 of multiple biological pathways implicated in ME by the LOCOME study.
Answered by Kanishka Narayan
The LOCOME study, led by Precision life, was funded by Innovate UK through the Advancing Precision Medicine programme. Reporting more than 250 core genes associated with ME, including 76 shared with long COVID, and dozens of drug repurposing opportunities, these findings have important implications for future ME and long COVID research, diagnosis and treatment development. UK Research and Innovation (UKRI) actively fosters collaboration with the private sector by combining the expertise of Innovate UK, which is fully business-focused, with the knowledge exchange expertise of Research England, and disciplinary expertise of their research councils. Innovate UK is well-positioned to collaborate with private-sector researchers on the findings of the LOCOME study.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →